Author + information
- Received May 3, 2012
- Accepted May 28, 2012
- Published online September 1, 2012.
- ↵⁎Reprint requests and correspondence:
Dr. Christoph M. Happel, Department of Pediatric Cardiology and Intensive Care Medicine, OE 6730, Medical School Hannover, 30625 Hannover, Germany
Several publications report strokes early after embolotherapy for pulmonary arteriovenous malformations (pAVM) (1–3). Various mechanisms are discussed for this event, including embolization of newly formed thrombotic material originating from the aneurysmal sac after occlusion of the arterial feeder (2).
To reduce the risk of peri-interventional stroke in a 22-year-old woman with a giant pAVM (66 × 47 × 70 mm3) (Figs. 1A and 1B), after occlusion of the main feeding artery (16-mm Vascular Plug II), we additionally blocked the draining vein via a transseptally advanced 18-mm Vascular Plug II (both devices: AGA Medical Corporation, Plymouth, Minnesota) (Fig. 1C). The patient recovered uneventfully; pulse oximetry rose from approximately 85% before intervention to 98%. Four months after embolotherapy, a computed tomography scan confirmed the excellent result (Fig. 1D). A minor residual pAVM was not targeted, because the patient refused a second procedure. Two years after embolotherapy, the patient is in good clinical condition without any neurological sequelae.
For accompanying videos, please see the online version of this article.
Dr. Bertram has received proctoring honoraria from AGA Medical Corporation. All other authors have stated that they have no relationships relevant to the contents of this paper to disclose.
- Received May 3, 2012.
- Accepted May 28, 2012.
- American College of Cardiology Foundation